Concepedia

Publication | Closed Access

INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION

76

Citations

17

References

2010

Year

Abstract

One-year results of intravitreal ranibizumab for myopic choroidal neovascularization are very promising. Additional prospective studies are necessary to better determine long-term efficacy and safety.

References

YearCitations

Page 1